TMC Venture Fund is the venture capital arm of Texas Medical Center Corporation, investing in early-stage healthcare and life sciences companies. It focuses on digital health, medical devices, and therapeutics, partnering with entrepreneurs shaping the future of global health.
33% of their portfolio is in Healthcare. Average disclosed round size is $20.6M (across 6 rounds with reported amounts).
Portfolio
6
Fund Size
$50M
Top Stage
Unknown
Last 12 Mo
0
Team
Emily Reiser, PhD
Gabrielle Guttman
Kelly Jameson, PhD
Marcus Nelson
Thomas Luby, PhD
William E. Cohn, MD, PhD
William F. McKeon
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| PPATH EX | Unknown | $5M | May 2025 |
| CCrossbridge Bio | Unknown | $10M | Jan 2024 |
| VVolnay | Series A | $28.4M | Jan 2024 |
| AAlleviant Medical, Inc. | Unknown | $75M | — |
 PATHEX | Unknown | $5M | — |
 CorInnova, Inc. | Unknown | $20K | — |
Top Co-Investors
Alexandria Venture Investments2 shared
IAG Capital Partners2 shared
Fitz Gate Ventures2 shared
Portal Innovations1 shared
CE Ventures1 shared
4BIO Capital1 shared
Cancer Focus Fund1 shared
Mission BioCapital1 shared
ShangBay Capital1 shared
RiverVest Venture Partners1 shared
Gilmartin Capital1 shared
S3 Ventures1 shared
Vensana Capital1 shared
Keiretsu Forum1 shared
Last updated: 8 September 2026